Evidence map›Paper›PMID 26125026›Full record

ReviewBioMed research international2015

Trends in IT Innovation to Build a Next Generation Bioinformatics Solution to Manage and Analyse Biological Big Data Produced by NGS Technologies.

Alexandre G de Brevern, Jean-Philippe Meyniel, Cécile Fairhead, Cécile Neuvéglise, Alain Malpertuy

Abstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexandre G de BrevernINSERM, U 1134, DSIMB, 75739 Paris, France ; University Paris Diderot, Sorbonne Paris Cité, UMR-S 1134, 75739 Paris, France ; Institut National de la Transfusion Sanguine (INTS), 75739 Paris, France ; Laboratoire d'Excellence GR-Ex, 75739 Paris, France.
Jean-Philippe MeynielIsoft, Les Algorithmes, Bâtiment Euclide, Route de l'Orme, 91190 Saint-Aubin, France.
Cécile FairheadInstitut de Génétique et Microbiologie, UMR 8621 CNRS-Université Paris Sud, Bât 400, UFR des Sciences, 91405 Orsay Cedex, France.
Cécile NeuvégliseINRA, UMR 1319 Micalis, 78352 Jouy-en-Josas, France ; AgroParisTech, UMR Micalis, 78352 Jouy-en-Josas, France.
Alain MalpertuyATRAGENE, 33-35 rue Ledru-Rollin, 94200 Ivry-sur-Seine, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequencing the human genome began in 1994, and 10 years of work were necessary in order to provide a nearly complete sequence. Nowadays, NGS technologies allow sequencing of a whole human genome in a few days. This deluge of data challenges scientists in many ways, as they are faced with data management issues and analysis and visualization drawbacks due to the limitations of current bioinformatics tools. In this paper, we describe how the NGS Big Data revolution changes the way of managing and analysing data. We present how biologists are confronted with abundance of methods, tools, and data formats. To overcome these problems, focus on Big Data Information Technology innovations from web and business intelligence. We underline the interest of NoSQL databases, which are much more efficient than relational databases. Since Big Data leads to the loss of interactivity with data during analysis due to high processing time, we describe solutions from the Business Intelligence that allow one to regain interactivity whatever the volume of data is. We illustrate this point with a focus on the Amadea platform. Finally, we discuss visualization challenges posed by Big Data and present the latest innovations with JavaScript graphic libraries.

Indexed as

SoftwareComputational BiologyDatabases, FactualGenomicsHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID26125026
PMCPMC4466500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.